Ensysce Biosciences, Inc. (ENSC) Earnings History
Annual and quarterly earnings data from 2017 to 2024
Loading earnings history...
ENSC EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ENSC Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | -38.6% | -129.2% | -153.3% |
| 2023 | -240.1% | -480.4% | -475.7% |
| 2022 | -686.1% | -959.9% | -957.9% |
| 2021 | 100.0% | -562.7% | -823.6% |
| 2020 | 100.0% | -41.0% | 1.4% |
Download Data
Export ENSC earnings history in CSV or JSON format
Free sign-in required to download data
Ensysce Biosciences, Inc. (ENSC) Earnings Overview
As of May 8, 2026, Ensysce Biosciences, Inc. (ENSC) reported trailing twelve-month net income of -$11M, reflecting +2.6% year-over-year growth. The company earned $-3.80 per diluted share over the past four quarters, with a net profit margin of -153.3%.
Looking at the long-term picture, ENSC's historical earnings data spans multiple years. The company achieved its highest annual net income of $56,770 in fiscal 2020.
Ensysce Biosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including COLL ($75M net income, 8.1% margin), PCRX ($9M net income, 1.0% margin), AVDL (-$278,000 net income, -28.9% margin), ENSC has room to improve margins relative to the peer group. Compare ENSC vs COLL →
ENSC Earnings vs Peers
Earnings metrics vs comparable public companies
ENSC Historical Earnings Data (2017–2024)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$8M | +24.7% | -$7M | $-4.57 | -153.3% | -129.2% |
| 2023 | -$11M | +56.1% | -$11M | $-4.69 | -475.7% | -480.4% |
| 2022 | -$24M | +16.9% | -$24M | $-139.44 | -957.9% | -959.9% |
| 2021 | -$29M | -51330.8% | -$20M | $-355.68 | -823.6% | -562.7% |
| 2020 | $56,770 | +100.6% | -$2M | $0.56 | 1.4% | -41.0% |
| 2019 | -$10M | -652.2% | -$9M | $0.24 | -572.7% | -485.7% |
| 2018 | -$1M | -4205.5% | $-959,000 | $-0.22 | - | - |
| 2017 | $-31,193 | - | $-147,000 | $-0.01 | - | - |
See ENSC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ENSC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ENSC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonENSC — Frequently Asked Questions
Quick answers to the most common questions about buying ENSC stock.
Is ENSC growing earnings?
ENSC EPS of $-3.80 reflects slowing growth at +2.6%, below the 5-year CAGR of N/A. TTM net income is $-11M. Expansion rate has moderated.
What are ENSC's profit margins?
Ensysce Biosciences, Inc. net margin is -153.3%, with operating margin at -129.2%. Below-average margins reflect competitive or cost pressures.
How consistent are ENSC's earnings?
ENSC earnings data spans 2017-2024. The current earnings trend is +2.6% YoY. Historical data enables comparison across business cycles.